Information Provided By:
Fly News Breaks for September 30, 2019
Sep 30, 2019 | 07:49 EDT
Cowen analyst Ritu Baral initiated Bellus Health with an Outperform based on its promising drug candidate in the potential blockbuster chronic cough market. The analyst said the drug currently in Phase 2 trial has a high likelihood of statistical success and is modeled to have $833M peak sales in the US.
News For BLU From the Last 2 Days
There are no results for your query BLU